The Board of Directors is responsible for the ultimate supervision and management of the Company, including the establishment of general strategies and guidelines, as well as for other matters which by law are under its non-transferable responsibility. To the extent permitted by law and except as otherwise provided in some cases in the Company's Articles of Incorporation and Organizational Regulations, the management of the Company's affairs is delegated to the Management Board pursuant to Organizational Regulations adopted by the Board of Directors.
|
|
|
Rolf Classon
Chairman of the Board
Chairman of the Nomination and Governance Committee
Since 2009, elected until 2014
1945, Swedish citizen
Chemical Engineer, Gothenburg School of Engineering
Pol. Mag., University of Gothenburg
Professional background
|
2005 - 2006
2002 - 2004
1995 - 2002
1991 - 1995
1990 - 1991
1984 - 1990
1979 - 1984
1974 - 1978
1969 - 1974
|
Hillenbrand Industries, interim President and CEO
Bayer HealthCare, CEO and Chairman of the
Executive Committee
Bayer Diagnostics, President
Bayer Diagnostics, Executive Vice President
Pharmacia Biosystems AB, President and COO
Pharmacia Development Company, Inc.,
President
Pharmacia AB Hospital Products Division,
President
Asbjorn Habberstad AB, Consultant
Pharmacia AB, Director, Organization
Development |
Other activities
Auxilium Pharmaceuticals, USA, Non-executive Chairman;
Hill-Rom Holdings, USA, Non-executive Chairman;
Fresenius Medical Care AG, Germany, member of the Board.
|
| |
|
|
 |
|
Heinrich Fischer
Vice-Chairman of the Board
Chairman of the Audit Committee
Member of the Nomination and Governance Committee
Since 2007, elected until 2014
1950, Swiss citizen
Master of Applied Physics & Electrical Engineering (ETH Zurich), MBA (University of Zurich)
Professional background
|
since 2007
1996 - 2007
1994 - 2005
1991 - 1996
1980 - 1990
|
DiamondScull AG, owner and Chairman of the Board
Delegate of the Board and Chief Executive Officer Saurer Group
Co-founder and Chairman of ISE (Integrated System Engineering)
Executive Vice President, Corporate Development at Oerlikon-Bührle Group
Director of Staff Technology and Executive Vice President at Balzers Division of Oerlikon-Bührle Group |
Other activities
Orell Füssli Holding AG, Chairman of the Board;
Schweiter AG, member of the Board;
Hilti AG, member of the Board;
CAMOX Fund, member of the Board;
Zhoulang Textile Machinery Ltd,China, Chairman of the Board;
Sensirion Holding AG, member of the Board;
|
| |
|
|
|
|
|
 |
|
Dr. Oliver Fetzer
Chairman of the Compensation Committee
Member of the Nomination and Governance Committee
Since 2011, elected until 2014
1964, US citizen
MBA, Carnegie Mellon University, Pittsburgh, USA
Ph.D. Pharmaceutical Sciences (Major: Medicinal Chemistry), Medical University of South Carolina, USA
Professional background
|
since 2009
2007 - 2008
2002 - 2007
1993 - 2002
|
Cerulean Pharma Inc., USA,
President and Chief Executive Officer, Member of the Board of Directors
Sabbatical
Cubist Pharmaceuticals, USA, various management positions, including Senior Vice President, Corporate Development and Research and Development
The Boston Consulting Group, USA, between 2000 and 2002 Managing Director and Partner, Boston |
Other activities
Auxilium Pharmaceuticals, USA, member of the Board
|
| |
|
|
 |
|
Dr. Karen Hübscher
Member of the Audit Committee
Since 2012, elected until 2014
1963, Swiss and British citizen
MBA (IMD Lausanne)
Ph.D. Natural Sciences, Molecular Biology (ETH Zurich)
Masters Degree, Animal Sciences (ETH Zurich)
Professional background
|
Since 2012
2009 - 2011
2006 - 2009
2000 - 2005
1995 - 2000
|
Founder and Managing Director of FibulaMedical AG
Novartis Vaccines & Diagnostics AG, Basel, Switzerland Head Public Health and Market Access Europe Member of the European Commercial Operations Leadership Team Site Head Novartis Vaccines & Diagnostics AG, Basel.
Novartis Vaccines & Diagnostics, Emeryville, CA, and Cambridge, MA, USA
Global Head Business Development und member of the Executive Committee and Innovation Board
Novartis, Basel, Switzerland
Global Head of Investor Relations
Novartis, Basel, Switzerland (until 1997 CIBA-Geigy)
Various positions |
Other activities
Dispopharma Distribution & Promotion Ltd., member of the Board
|
| |
|
|
 |
|
Dr. Christa Kreuzburg
Member of the Compensation Committee
Since 2013, elected until 2014
1959, German citizen
Diploma and Ph.D. in Physical Chemistry, Duisburg University, Chemical Faculty
Professional background
|
Since 2009
2007 - 2008
2006 - 2007
2002 - 2005
2000 - 2002
1997 - 1999
1994 - 1996
1990 - 1994
|
Consulting projects for small and mid-size Healthcare companies
Bayer HealthCare, Berlin, Germany
Head of Bayer Schering Pharma Europe/Canada and member of the Executive Committee
Bayer HealthCare, Leverkusen, Germany
Head of Pharma Primary Care / International Operations and member of the Pharma Management Committee
Bayer HealthCare, Leverkusen, Germany
Head of Pharma Japan (from 2004) / Europe / MERA and member of the Pharma Management Committee
Bayer AG, Leverkusen, Germany Head of Corporate Strategic Planning
Bayer AG, Leverkusen, Germany
Head of Corporate Strategic Planning
Bayer AG, Leverkusen, Germany
Departmental Head, Central Research
Bayer AG, Leverkusen, Germany
Laboratory Head, Central Research |
Other activities
none
|
|
|
|
| |
|
|
 |
|
Gérard Vaillant
Acting Chief Executive Officer (CEO) from February 2012 until October 2012
(therefore resigned as Member of the Audit Committee in April 2012)
Since 2004, elected until 2014
1942, US citizen
Degree in Marketing (École Supérieure de Commerce, Paris) and MS (University of Sciences, Paris)
Professional background:
|
1995 - 2004
1992 - 1995
1987 - 1992
|
Johnson & Johnson, Company Group Chairman Diagnostics Worldwide; Member of the Medical Devices & Diagnostics Group Operating Committee of J&J until retirement in 2004
Worldwide President LifeScan (a J&J company), and Company Group Chairman Diagnostics Worldwide
Various senior management positions within Johnson & Johnson (US), including Vice-President, J&J International |
Other activities
Theradiag SA, France, member of the Board;
Safe Orthopaedics, France, Chairman of the Board;
Patho Quest S.A.S., France, Chairman of the Board;
STAT-Diagnostica & Innovation S.L.,Spain, Chairman of the Board
|
|
| |
|
|
 |
|
Erik Walldén
Member of the Audit Committee
Since 2011, elected until 2014
1949, Swedish citizen
Chemical Engineer, Uppsala University, Sweden
Professional background
|
Since 2009
2007 - 2009
Since 2006
2004 - 2006
1998 - 2003
1997 - 1998
1994 - 1997
1992 - 1994
1989 - 1992
1986 - 1989
1982 - 1986
1976 - 1982
1974 - 1976
|
Gyros AB, Sweden, CEO
CEO Affibody Holding AB
Chairman and President,
WalldenAssociates (Erik Walldén AB)
President and CEO, Biacore International AB
President and CEO, Pyrosequencing AB
Vice President, Chromatography Products, PerSeptive Biosystems (Applera Corporation), USA
Vice President, Worldwide Marketing & Support, PerSeptive Biosystems, USA
Managing Director, Cobalt Trading Relations AB; Vice President Worldwide Marketing, Sales and Support, Biosensor AB
(today Biacore International AB)
Director, Pharmacia LKB Biotechnology AB, Molecular Biology Division
Various marketing positions,
Pharmacia Biotechnology AB
Various R&D positions,
Pharmacia Biotechnology AB
Research Assistant,
Royal Institute of Technology, Stockholm |
Other activities
Member of Industrial Supervisory Board of Healthinvest Partners AB; Deputy Chairman, Exiqon A/S;
Chairman Business & Finance Work Group, Sweden-BIO;
Member of Board of Genovis AB
|
|
© 2013, Tecan Trading AG, Switzerland, all rights reserved. Disclaimer | Trademarks | Sitemap